MiR-204-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Esophageal Squamous Cell Carcinoma by Regulating Nestin
Overview
Affiliations
Esophageal cancer (EC) is a highly malignant gastrointestinal tumor, and esophageal squamous cell carcinoma (ESCC) is one of the most common histological types of EC. MicroRNAs (miRNAs) are small noncoding RNAs closely related to tumorigenesis and tumor progression. In addition, Nestin is an intermediate filament protein (class VI) and contributes to the progression of numerous tumors. However, the correlation between miRNAs and Nestin in ESCC remains unclear. This study aimed to investigate the relationship between miR-204-5p and Nestin in ESCC. First, Nestin-related miRNAs in ESCC were explored using RNA sequencing. In ESCC tissues and cell lines, the expression of miR-204-5p was decreased detected by quantitative real-time polymerase chain reaction (qPCR), whereas Nestin protein level was upregulated identified by Western blotting (WB). Besides, Nestin was the direct target of miR-204-5p in ESCC determined via the luciferase reported assay. Moreover, miR-204-5p regulated Nestin to inhibit ESCC cell proliferation detected by the colony formation assay and promote ESCC cell apoptosis identified using the flow cytometry and TUNEL assay. Furthermore, miR-204-5p suppressed tumorigenesis evaluated by the murine xenograft tumor model. In conclusion, these results indicated that miR-204-5p inhibited cell proliferation and induced cell apoptosis in ESCC through targeting Nestin, which might provide novel therapeutic targets for ESCC therapy.
An P, Li X, Zhao Y, Li L, Wang Y, Wang W Ren Fail. 2025; 47(1):2444393.
PMID: 40038566 PMC: 11884099. DOI: 10.1080/0886022X.2024.2444393.
Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications.
He Z, Ji Y, Yuan Y, Liang T, Liu C, Jiao Y Front Pharmacol. 2025; 16:1532558.
PMID: 39944625 PMC: 11814179. DOI: 10.3389/fphar.2025.1532558.
Novel miRNA markers and their mechanism of esophageal squamous cell carcinoma (ESCC) based on TCGA.
Yuan P, Gao X, Xu M, Qiu L, Xiong Z, Shen J Sci Rep. 2024; 14(1):27261.
PMID: 39516222 PMC: 11549395. DOI: 10.1038/s41598-024-76321-0.
Ma X, Chen Z, Chen W, Chen Z, Shang Y, Zhao Y J Exp Clin Cancer Res. 2024; 43(1):20.
PMID: 38229152 PMC: 10790371. DOI: 10.1186/s13046-023-02939-z.
Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics.
Jo H, Shim K, Jeoung D Int J Mol Sci. 2022; 23(11).
PMID: 35682560 PMC: 9180509. DOI: 10.3390/ijms23115881.